Profil
Naoki Kobayashi is a professional with experience in finance and management.
He is currently working as the Chief Financial Officer at Hatena, Inc. and as the Chief Financial Officer & Executive Officer at Modalis Therapeutics Corp.
In the past, he worked as a Director at Oncolys BioPharma, Inc. and as the Chief Financial Officer, Director & IR Contact at Hatena Co., Ltd. Mr. Kobayashi holds a Master's degree in Business Administration from the University of Hitotsubashi.
Postes actifs de Naoki Kobayashi
| Sociétés | Poste | Début |
|---|---|---|
| MODALIS THERAPEUTICS CORPORATION | Directeur Financier/CFO | - |
Hatena, Inc. | Directeur Financier/CFO | 01/07/2013 |
Anciens postes connus de Naoki Kobayashi
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOLYS BIOPHARMA INC. | Directeur/Membre du Conseil | 28/03/2019 |
| HATENA CO., LTD. | Directeur Financier/CFO | 01/10/2017 |
Formation de Naoki Kobayashi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of Hitotsubashi
University of Hitotsubashi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncolys BioPharma, Inc.
Oncolys BioPharma, Inc. BiotechnologyHealth Technology Engages in the research and development of oncolytic viruses, drugs for serious infectious diseases, molecular targeted anti-cancer drugs, and tumor diagnostic agents | Health Technology |
Hatena Co., Ltd.
Hatena Co., Ltd. Packaged SoftwareTechnology Services Develops administration software and operates contents platform for advertising industries | Technology Services |
Hatena, Inc. | |
Modalis Therapeutics Corp.
Modalis Therapeutics Corp. BiotechnologyHealth Technology Develops transformative therapeutics for diseases which are caused by malfunctioning of genes | Health Technology |
















